| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.4 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |